TabsDetailsBasic DetailsDate Posted: Monday, January 4, 2021Status: CompleteMedical Product: abacavir, carbamazepine, clopidogrel, phenytoinDescription: In this request, we investigated use of abacavir, carbamazepine, clopidogrel, and phenytoin and several genetic testing procedures in the Mini‐Sentinel Distributed Database (MSDD).The study period included data from January 1, 2007 to December 31, 2012. We distributed this request to 17 Data Partners on April 16, 2014. Read More Deliverables (1)Mini-Sentinel Modular Program Report: Abacavir, Carbamazepine, Clopidogrel, and Phenytoin Use: A Descriptive AnalysisAdditional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2007 - December 31, 2012Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Mini-Sentinel Distributed Database (MSDD)
